Cytosorbents Corp Files 2024 Annual Report
Ticker: CTSO · Form: 10-K · Filed: Mar 31, 2025 · CIK: 1175151
| Field | Detail |
|---|---|
| Company | Cytosorbents CORP (CTSO) |
| Form Type | 10-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, financials, medical-devices
TL;DR
Cytosorbents filed its 2024 10-K. Financials and biz ops detailed.
AI Summary
Cytosorbents Corporation filed its 10-K for the fiscal year ending December 31, 2024. The company, formerly known as MedaSorb Technologies CORP and GILDER ENTERPRISES INC, is based in Princeton, NJ. The filing details financial performance and business operations for the period.
Why It Matters
This 10-K filing provides investors and stakeholders with a comprehensive overview of Cytosorbents Corporation's financial health and strategic direction for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a publicly traded company, Cytosorbents faces inherent market, regulatory, and operational risks detailed within its 10-K filing.
Key Numbers
- 4027003 — P1Y (Likely represents a financial metric for the prior year, requiring further context from the full filing.)
- 2732907 — P5D (Likely represents a financial metric, requiring further context from the full filing.)
- 3770681 — P5D (Likely represents a financial metric, requiring further context from the full filing.)
Key Players & Entities
- Cytosorbents Corporation (company) — Filer of the 10-K
- MedaSorb Technologies CORP (company) — Former company name
- GILDER ENTERPRISES INC (company) — Former company name
- Princeton, NJ (location) — Company business address
- December 31, 2024 (date) — Fiscal year end
- 20250331 (date) — Filing date
FAQ
What were Cytosorbents Corporation's total revenues for the fiscal year ended December 31, 2024?
The provided text does not contain specific revenue figures for December 31, 2024. Further review of the full 10-K document is needed.
What is the company's primary business segment as described in the 10-K?
The filing indicates Cytosorbents Corporation operates within the 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS' industry, SIC code 3841.
When did Cytosorbents Corporation change its name from MedaSorb Technologies CORP?
The date of the name change from MedaSorb Technologies CORP to Cytosorbents Corporation was August 7, 2006.
What is the company's state of incorporation?
Cytosorbents Corporation is incorporated in Delaware (DE).
What is the filing date of this 10-K report?
This 10-K report was filed on March 31, 2025.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding Cytosorbents Corp (CTSO).